APC and neoplasm: Furthermore, we have previously conducted Transcriptomic Affymetrix microarray analysis [5, 6] and proteomic profiling using iTRAQ-QSTAR [7] to identify genes that are mis-regulated at these early stages of neoplasia following the loss of Apc, and thereby identify factors that potentially contribute to CRC pathogenesis.